A newly published study of 3,592 transgender, nonbinary, and gender-diverse (TGD) patients found that 15% of patients with ...
HealthDay News — Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in US transgender, nonbinary, and gender-diverse (TGD) ...
The change limits treatment options for veterans with gender dysphoria, who are up to 20 times more likely to experience suicidal thoughts.